HCC risk in patients who are HBeAg-positive and have chronic hepatitis B under long-term nucleos(t)ide analogue therapy: New insights from Asia

Hepatology. 2024 Feb 16. doi: 10.1097/HEP.0000000000000796. Online ahead of print.

Authors

George Papatherodoridis¹, Pietro Lampertico^{2

3}

Affiliations

¹ Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens "Laiko", Athens, Greece.
² Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
³ Department of Pathophysiology and Transplantation, CRC "A.M. and A. Migliavacca" Center for Liver Disease, University of Milan, Milan, Italy.

PMID: 38373094
DOI: 10.1097/HEP.0000000000000796

No abstract available